Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of a Human Monoclonal Antibody for Inhalational Anthrax
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Preclinical drug development in pancreatic cancer
Mechanisms of Chronic Inflammation and Neuroprotection in Ad
Efficacy/Safety of Mycophenolate Mofetil Immunotherapy in Rheumatoid Arthritis
Novel Method for Antisense Targeting
Pathogenesis of NON-01 Vibrio Cholerae
Recently added grants:
Adipokines as Biomarkers of Cachexia and High-Risk Rheumatoid Arthritis
Fear Reversal Learning in Combat-Related PTSD: A Multi-Model fMRI-PET Approach
Neural microcircuit selection by astrocyte signaling following cocaine exposure
Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF
Integrating Systems of VA and non-VA Care Delivery in the Evolving VA Community Care Network
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272200700033C-2-0-1
Application #
7567309
Study Section
Project Start
2007-09-28
Project End
2011-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 AI
Development of a Human Monoclonal Antibody for Inhalational Anthrax
/ Pharmathene, Inc.
$1,998,109
NIH 2007
N01 AI
Development of a Human Monoclonal Antibody for Inhalational Anthrax
/
Comments
Be the first to comment on this grant